Guardant Health
GH
#1166
Rank
S$25.93 B
Marketcap
S$195.56
Share price
-1.69%
Change (1 day)
195.72%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): S-$4.35

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is S-$4.39. In 2025 the company made an earnings per share (EPS) of S-$4.28 an increase over its 2024 EPS that were of S-$4.61.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$4.351.5%
2025S-$4.28-7.02%
2024S-$4.61-16.82%
2023S-$5.54-33.13%
2022S-$8.2860%
2021S-$5.1855.04%
2020S-$3.34207.14%
2019S-$1.09-19.81%
2018S-$1.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
S-$3.63-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
S-$3.21-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA